U.S. Physical Therapy, Inc. (USPH) Stock Forecast
USPH analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.14 / 5 from 7 analysts
- Price target
- $97.00 average of analyst targets
- Upside to target
- +13.2% from the latest close
- Next earnings
- November 4, 2026 EPS estimate $0.76
- 52-week range
- $59.00 – $93.16
USPH analyst ratings
7 analystsNumber of analysts at each rating.
USPH price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
USPH earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.73 | $0.57 | $0.90 | $0.66 | +10.6% | 6 |
| Current fiscal year (2026) | $2.90 | $2.70 | $3.18 | $2.63 | +10.2% | 5 |
| Next fiscal year (2027) | $3.35 | $2.98 | $3.80 | $2.90 | +15.6% | 6 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
USPH revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $214.5M | $212.2M | $216.3M | +8.8% | 7 |
| Current fiscal year (2026) | $847.9M | $842.0M | $851.0M | +8.6% | 7 |
| Next fiscal year (2027) | $912.0M | $895.1M | $935.9M | +7.6% | 7 |
USPH EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
USPH revenue: reported and forecast
USPH EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.78 | $0.80 | $0.77 | $0.75 | $0.73 | −6.9% | 1 up · 1 down |
| Current fiscal year (2026) | $2.81 | $2.93 | $2.89 | $2.89 | $2.90 | +3.2% | 1 up · 0 down |
| Next fiscal year (2027) | $3.41 | $3.41 | $3.44 | $3.38 | $3.35 | −1.8% | 1 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
USPH earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; USPH beat in 5 of 12.
What analysts expect from USPH
7 analysts cover U.S. Physical Therapy; their consensus rating is buy (4.14 on a 1–5 scale, where 5 is a strong buy). The average price target is $97.00, 13.2% above the latest close of $85.71. Analysts expect earnings of $2.90 per share for 2026, +10.2% from a year earlier. For 2027 the average estimate is $3.35 per share on revenue of $912.0 million. U.S. Physical Therapy beat the EPS estimate in 5 of the last 12 quarters.
Related: USPH income statement, USPH key metrics, USPH chart. See the USPH stock overview for the latest quote and news.
USPH forecast FAQ
What is U.S. Physical Therapy's price target?
The average analyst price target for U.S. Physical Therapy is $97.00, 13.2% above the latest close of $85.71.
Is U.S. Physical Therapy a buy, hold or sell?
Of 7 analysts covering U.S. Physical Therapy, 2 rate it a strong buy, 4 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is U.S. Physical Therapy's EPS forecast?
Analysts forecast $2.90 per share for 2026 (range $2.70 to $3.18); for 2027 the estimate is $3.35.
What is U.S. Physical Therapy's revenue forecast?
The average revenue estimate for 2026 is $847.9 million, growth of 8.6%; for 2027 it is $912.0 million.
When does U.S. Physical Therapy report earnings?
U.S. Physical Therapy is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 after the market closes; the EPS estimate is $0.76.
Does U.S. Physical Therapy usually beat earnings estimates?
U.S. Physical Therapy reported EPS at or above the analyst estimate in 5 of the last 12 quarters.